Rosenblatt analyst Chris Brendler lowered the firm’s price target on Gemini (GEMI) to $26 from $30 and keeps a Buy rating on the shares. The firm views the company’s Q3 report as “more mixed than expected” with its revenue growth more than offset by significantly higher than expected expense growth. The firm agrees with Gemini’s “aggressive approach” to its current growth and remains optimistic about the company’s “significant growth potential.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEMI:
- Gemini price target lowered to $16 from $23 at Citi
- Cautious Hold Rating on Gemini Space Station, Inc.: Balancing Growth Potential with Profitability Concerns
- Gemini Reports Steady Third Quarter 2025 Results
- Closing Bell Movers: CoreWeave down over 5% on lower sales, higher capex view
- Gemini Space Station, Inc. options imply 10.3% move in share price post-earnings